Precision for Medicine Announces Culmination of Next Generation Sequencing Initiative


Precision for Medicine announced the culmination of its Next Generation Sequencing (NGS) initiative which improved the accuracy and speed of identifying cancer mutations in solid tumors, allowing researchers and manufacturers to develop patient-specific diagnostics for improved clinical outcomes.

Read more about the initative here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.